Study of Nuts and Dried Fruits Consumption in Adolescents in Relation to Risk of Metabolic Syndrome and Its Components: Tehran Lipid and Glucose Study
International Journal of Nutrition and Food Sciences
Volume 5, Issue 1-2, February 2016, Pages: 8-13
Received: Jul. 28, 2015;
Accepted: Jul. 30, 2015;
Published: Jan. 13, 2016
Views 4370 Downloads 133
Parvin Mirmiran, Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Shirin Ghotboddin Mohammadi, Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Zahra Bahadoran, Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Fereidoun Azizi, Endocrine Research Center, Research Institute of Endocrinology and Metabolism, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Background and aim. This study was conducted to investigate the association of consumption of nuts and dried fruits with the risk of metabolic syndrome (MetS) and its components adolescents. Material and Methods. In this cross-sectional study was conducted in 785 adolescents, aged 10-19 y, participated in the fourth phase of the Tehran Lipid and Glucose Study. Demographics, anthropometrics and biochemical measurements were evaluated. MetS and its components were defined based on a modified definition of de Ferranti. Usual dietary intakes were assessed using a validated semi-quantitative food frequency questionnaire. Dried fruits and nuts were included dried figs, raisins, dried berries, peanuts, almonds, walnuts, pistachios, hazelnuts and seeds. To determine the prevalence of metabolic syndrome in quartiles of dried fruits and nuts consumption, logistic regression models adjusted for confounding variables were used. Results. Mean age and body mass index of participants (47% male) was 14.8±2.9 years, and 22.1 ± 4.7 kg/m2, respectively. The prevalence of MetS was 22.2% (girls: 19.5% and boys: 25.2%). In the highest compared to lowest quartile of nuts and dried fruits, the prevalence of lipid disorders, abdominal obesity and MetS was non-significantly lower. Serum triglycerides significantly decreased across increasing consumption of nuts and dried fruits (P<0.05). After adjustment for confounding variables, the odds of MetS in the highest compared to the lowest quartile of nuts and dried fruits were 0.65 (95% CI: 0.4-1.1). Conclusion. Increased consumption of nuts and dried fruits could have favorable effect in prevention of metabolic syndrome and its components.
Shirin Ghotboddin Mohammadi,
Study of Nuts and Dried Fruits Consumption in Adolescents in Relation to Risk of Metabolic Syndrome and Its Components: Tehran Lipid and Glucose Study, International Journal of Nutrition and Food Sciences. Special Issue: Nutrition and Cardiometabolic Risk Factors.
Vol. 5, No. 1-2,
2016, pp. 8-13.
Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation. 2008 Feb 12; 117(6): 754-61.
O'Neil CE, Keast DR, Nicklas TA, Fulgoni VL, 3rd. Nut consumption is associated with decreased health risk factors for cardiovascular disease and metabolic syndrome in U.S. adults: NHANES 1999-2004. J Am Coll Nutr. 2011 Dec; 30(6): 502-10.
Brennan AM, Sweeney LL, Liu X, Mantzoros CS. Walnut consumption increases satiation but has no effect on insulin resistance or the metabolic profile over a 4-day period. Obesity (Silver Spring). 2010 Jun; 18(6): 1176-82.
Ibarrola-Jurado N, Bullo M, Guasch-Ferre M, Ros E, Martinez-Gonzalez MA, Corella D, et al. Cross-sectional assessment of nut consumption and obesity, metabolic syndrome and other cardiometabolic risk factors: the PREDIMED study. PLoS One. 2013; 8(2): e57367.
Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009; 10(1): 5.
Willett W. Issues in analysis and presentation of dietary data. Nutritional epidemiology. 1998; 2: 321-45.
Kelishadi R, Ardalan G, Gheiratmand R, Majdzadeh R, Hosseini M, Gouya M, et al. Thinness, overweight and obesity in a national sample of Iranian children and adolescents: CASPIAN Study. Child: care, health and development. 2008; 34(1): 44-54.
Mirmiran P, Hosseini Esfahani F, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran Lipid and Glucose Study. Public health nutrition. 2010; 13(05): 654-62.
Ghaffarpour M, Houshiar-Rad A, Kianfar H. The manual for household measures, cooking yields factors and edible portion of foods. Tehran: Nashre Olume Keshavarzy. 1999: 1-40.
Azar M, Sarkisian E. Food composition table of Iran. Tehran: National Nutrition and Food Research Institute, Shaheed Beheshti University. 1980; 65.
USDA. USDA national nutrient database for standard reference, release 21. US Department of Agriculture; 2011 [cited 2011]; Available from: http://www.nal.usda.gov/fnic/foodcomp/search/.
de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004; 110(16): 2494-7.
Kelishadi R, Gouya MM, Ardalan G, Hosseini M, Motaghian M, Delavari A, et al. First reference curves of waist and hip circumferences in an Asian population of youths: CASPIAN study. Journal of tropical pediatrics. 2007; 53(3): 158-64.
Fereidoun Azizi M, Davood Khalili M, Hassan Aghajani M, Alireza Esteghamati M, Farhad Hosseinpanah M, Alireza Delavari M, et al. Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Archives of Iranian medicine. 2010; 13(3): 243.
CDC. Data Table of Stature-for-age Charts. 2012 [cited 2012 23 jun]; Available from: http://www.cdc.gov/growthcharts/htmlcharts/statge.htm.
NHBPEP. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114(2): 555-76.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005; 112(17): 2735-52.
Bes-Rastrollo M, Sabate J, Gomez-Gracia E, Alonso A, Martinez JA, Martinez-Gonzalez MA. Nut consumption and weight gain in a Mediterranean cohort: The SUN study. Obesity (Silver Spring). 2007 Jan; 15(1): 107-16.
Casas-Agustench P, Lopez-Uriarte P, Bullo M, Ros E, Cabre-Vila JJ, Salas-Salvado J. Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis. 2011 Feb; 21(2): 126-35.
Bes-Rastrollo M, Wedick NM, Martinez-Gonzalez MA, Li TY, Sampson L, Hu FB. Prospective study of nut consumption, long-term weight change, and obesity risk in women. Am J Clin Nutr. 2009 Jun; 89(6): 1913-9.
Martinez-Gonzalez MA, Bes-Rastrollo M. Nut consumption, weight gain and obesity: Epidemiological evidence. Nutr Metab Cardiovasc Dis. 2011 Jun; 21 Suppl1: S40-5.
Fernandez-Montero A, Bes-Rastrollo M, Beunza JJ, Barrio-Lopez MT, de la Fuente-Arrillaga C, Moreno-Galarraga L, et al. Nut consumption and incidence of metabolic syndrome after 6-year follow-up: the SUN (Seguimiento Universidad de Navarra, University of Navarra Follow-up) cohort. Public Health Nutr. 2013 Nov; 16(11): 2064-72.
Djousse L, Rudich T, Gaziano JM. Nut consumption and risk of hypertension in US male physicians. Clin Nutr. 2009 Feb; 28(1): 10-4.
Martinez-Lapiscina EH, Pimenta AM, Beunza JJ, Bes-Rastrollo M, Martinez JA, Martinez-Gonzalez MA. Nut consumption and incidence of hypertension: the SUN prospective cohort. Nutr Metab Cardiovasc Dis. 2010 Jun; 20(5): 359-65.
O'Neil CE, Keast DR, Nicklas TA, Fulgoni VL, 3rd. Out-of-hand nut consumption is associated with improved nutrient intake and health risk markers in US children and adults: National Health and Nutrition Examination Survey 1999-2004. Nutr Res. 2012 Mar;32(3):185-94.
Sabate J, Oda K, Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med. 2010 May 10; 170(9): 821-7.
Ros E. Health benefits of nut consumption. Nutrients. 2010 Jul; 2(7): 652-82.
Kendall CW, Josse AR, Esfahani A, Jenkins DJ. Nuts, metabolic syndrome and diabetes. Br J Nutr. 2010 Aug; 104(4): 465-73.
Coates AM, Howe PR. Edible nuts and metabolic health. Curr Opin Lipidol. 2007 Feb; 18(1): 25-30.
Segura R, Javierre C, Lizarraga MA, Ros E. Other relevant components of nuts: phytosterols, folate and minerals. Br J Nutr. 2006 Nov; 96 Suppl 2: S36-44.
Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005 Feb; 81(2): 341-54.
Nath KA. Homocysteine and atherothrombosis. N Engl J Med. 1998 Aug 13; 339(7): 478-9.
Garrido I, Monagas M, Gomez-Cordoves C, Bartolome B. Polyphenols and antioxidant properties of almond skins: influence of industrial processing. J Food Sci. 2008 Mar; 73(2): C106-15.
Rahman I, Biswas SK, Kirkham PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol. 2006 Nov 30; 72(11): 1439-52.
Zhao G, Etherton TD, Martin KR, Gillies PJ, West SG, Kris-Etherton PM. Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. Am J Clin Nutr. 2007 Feb; 85(2): 385-91.
Zhao G, Etherton TD, Martin KR, West SG, Gillies PJ, Kris-Etherton PM. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr. 2004 Nov; 134(11): 2991-7.
Papoutsi Z, Kassi E, Chinou I, Halabalaki M, Skaltsounis LA, Moutsatsou P. Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br J Nutr. 2008 Apr; 99(4): 715-22.
Karlsson S, Nanberg E, Fjaeraa C, Wijkander J. Ellagic acid inhibits lipopolysaccharide-induced expression of enzymes involved in the synthesis of prostaglandin E2 in human monocytes. Br J Nutr. 2010 Apr; 103(8): 1102-9.